Cell and Gene Commercialization

  1. Innovation That Is Evolving The CGT Landscape In 2025 7/28/2025

    Uncover how cell and gene therapy leaders are adapting to funding pressures, regulatory shifts, and global complexity by prioritizing scalability and strategic partnerships for long-term success.

  2. How Smart Planning Helps CGT Scale Further, Faster 7/25/2025

    Henrik Anderson, former SVP and Head of Cell Therapy Technology Development at Bristol Myers Squibb, explores how early planning, automation, and economic discipline can help scale the impact of cell therapies.

  3. Navigating The CGT Supply Chain: Key Logistical Challenges And Solutions 7/16/2025

    Commercializing cell and gene therapies requires overcoming complex logistical hurdles. Customized strategies for temperature control, compliance, and end-to-end delivery are crucial to prevent supply chain issues.

  4. Advanced Manufacturing And CDMOs Are Rewriting The CGT Cost Equation 7/16/2025

    Without contract manufacturers, small biotechs often don't stand a chance of reaching commercial production scales, let alone global access for their drugs.

  5. Redefining CGT With Exosomes And EVs 7/16/2025

    July’s Cell & Gene Live featured a comprehensive look at the scientific advances, clinical promise, manufacturing hurdles, and regulatory considerations shaping extracellular vesicle and exosome-based therapies. 

  6. Ori Spotlight: Investor Confidence In Advanced Therapies Is Critical For Long-Term Success 7/9/2025

    Endpoints News founder Arsalan Arif shares his journey and unpacks the cell and gene therapy market, from investor sentiment to the challenges of scaling innovation.

  7. Commercializing Your First Cell Or Gene Therapy (CGT): Developing Your Market Access Strategy 7/2/2025

    Effectively commercializing cell and gene therapies requires a strong market access strategy. Learn key steps for ensuring your therapy reaches patients at the right time and place.

  8. Integrated Services: Expertise At Every Step 7/2/2025

    Bringing cell and gene therapies to market is complex, but with the right partner, you can overcome challenges and simplify, support, and scale your therapy from development to commercialization.

  9. How CGT Leaders Are Reducing Failures, Scaling Processes, And Overcoming Regulatory Friction 6/30/2025

     Industry leaders share their philosophy on reducing product failure, embracing AI, and building dynamic teams to stay ahead of the curve to bring curative CGT therapies to patients.

  10. Ori Spotlight: How Early Automation Strategies Reduce Costs And Improve Patient Access 6/20/2025

    A pioneer in regenerative medicine reveals how to bridge the gap from research to reality. Learn how early automation and strategic partnerships can slash costs and expand patient access to therapies.